VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹156 Cr | ₹86 Cr | ₹37 Cr | ₹37 Cr | ₹41 Cr |
What is the latest Cash Flow from Operating Activities ratio of VENUS REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹156 Cr |
| Mar2025 | ₹86 Cr |
| Mar2024 | ₹37 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹41 Cr |
How is Cash Flow from Operating Activities of VENUS REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹156 Cr | 80.20 | |
| Mar2025 | ₹86 Cr | 131.84 | |
| Mar2024 | ₹37 Cr | 1.80 | |
| Mar2023 | ₹37 Cr | -10.89 | |
| Mar2022 | ₹41 Cr | - | |
Compare Cash Flow from Operating Activities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,071.9 Cr | -4% | -13.9% | 189.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -4% |
-13.9% |
189.8% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses